Skip to main content
Top
Published in: Dermatology and Therapy 1/2017

Open Access 01-03-2017 | Original Research

Cosmetics Use-Related Adverse Events and Determinants Among Jigjiga Town Residents, Eastern Ethiopia

Authors: Arebu I. Bilal, Zelalem Tilahun, Ebrahim D. Osman, Anwar Mulugeta, Muktar Shekabdulahi, Derbew Fikadu Berhe

Published in: Dermatology and Therapy | Issue 1/2017

Login to get access

Abstract

Introduction

Non-medicated cosmetics use is very common among the Ethiopian population. However, little is known about these products’ related adverse events. The aim of this study was to assess the prevalence and determinants of cosmetics-related adverse events among Jigjiga Town residents, Eastern Ethiopia.

Methods

A community-based cross-sectional study design was conducted in May and June 2014. Semi-structured interviews were used to collect cosmetics use pattern and related adverse events. For assessing determinants, logistic regression was used and statistical significance was set at p < 0.05.

Results

Overall, 600 participants were approached with a 93% response rate. Ninety-three percent (n = 521) of them reported the use of cosmetics at least once within 2 weeks prior to this study, and of these, 229 (44%) used traditional herbal cosmetics along with modern cosmetics. A total of 342 (61%) reported experiencing adverse events of which the most common reported were: allergic reactions, 149 (36%); the appearance of acne, 66 (16%); and hirsutism, 52 (12.5%). The occurrence of cosmetics-related adverse events were significantly associated with the number of cosmetics used per day, the frequency of use, mixing of different types of cosmetics together, and mixing of cosmetics with water or saliva.

Conclusion

A higher proportion of cosmetic users reported experiencing at least one adverse event. The number of cosmetic products and frequency of use were important predictors for experiencing adverse events. This implies the need to consider safety concerns related to cosmetic use. Approaches to address such issues may include awareness creation programs and promoting the concept of cosmetovigilance among cosmetic sellers, users, and other stakeholders.
Literature
2.
go back to reference Sautebin L. Understanding the adverse effects of cosmetics: a pilot project in cosmetovigilance. Drug Saf. 2008;31(5):433–6.CrossRefPubMed Sautebin L. Understanding the adverse effects of cosmetics: a pilot project in cosmetovigilance. Drug Saf. 2008;31(5):433–6.CrossRefPubMed
4.
go back to reference Eisenburg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States: prevalence, costs and pattern use. N Engl J Med. 1993;328:246–52.CrossRef Eisenburg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States: prevalence, costs and pattern use. N Engl J Med. 1993;328:246–52.CrossRef
5.
go back to reference Berne B, Lundin A, Enander Malmros I. Side effects of cosmetics and toiletries in relation to use. A retrospective study in a Swedish population. Eur J Dermatol. 1994;4:189–93. Berne B, Lundin A, Enander Malmros I. Side effects of cosmetics and toiletries in relation to use. A retrospective study in a Swedish population. Eur J Dermatol. 1994;4:189–93.
6.
go back to reference Orton DI, Wilkinson JD. Cosmetic allergy: incidence, diagnosis, and management. Am J Clin Dermatol. 2004;5:327–37.CrossRefPubMed Orton DI, Wilkinson JD. Cosmetic allergy: incidence, diagnosis, and management. Am J Clin Dermatol. 2004;5:327–37.CrossRefPubMed
7.
go back to reference Willis CM, Shaw S, De Lacharriere O, et al. Sensitive skin: an epidemiological study. Br J Dermatol. 2001;145:258–63.CrossRefPubMed Willis CM, Shaw S, De Lacharriere O, et al. Sensitive skin: an epidemiological study. Br J Dermatol. 2001;145:258–63.CrossRefPubMed
8.
go back to reference Giovanni CD, Arcoracid V, Gambardella L. Cosmetovigilance survey: are cosmetics considered safe by consumers. Pharmacol Res. 2006;53:16–21.CrossRefPubMed Giovanni CD, Arcoracid V, Gambardella L. Cosmetovigilance survey: are cosmetics considered safe by consumers. Pharmacol Res. 2006;53:16–21.CrossRefPubMed
10.
go back to reference Vigan M, Castelain F. Cosmetovigilance: definition, regulation and use “in practice”. Eur J Dermatol. 2014;24:643–9.PubMed Vigan M, Castelain F. Cosmetovigilance: definition, regulation and use “in practice”. Eur J Dermatol. 2014;24:643–9.PubMed
12.
go back to reference Echols MA. Food safety regulation in the European Union and the United States: different cultures, different laws. Colum J Eur L. 1998;4:525. Echols MA. Food safety regulation in the European Union and the United States: different cultures, different laws. Colum J Eur L. 1998;4:525.
13.
go back to reference Marie L, Louise U, Jorgen S. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics. Acta Derm Venereol. 2007;87:485–92.CrossRef Marie L, Louise U, Jorgen S. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics. Acta Derm Venereol. 2007;87:485–92.CrossRef
17.
go back to reference Cortez-Pereira CS, Baby AR, Velasco MV. Fragrance technology for the dermatologist—a review and practical application. J Cosmet Dermatol. 2010;9:230–41.CrossRefPubMed Cortez-Pereira CS, Baby AR, Velasco MV. Fragrance technology for the dermatologist—a review and practical application. J Cosmet Dermatol. 2010;9:230–41.CrossRefPubMed
18.
go back to reference Mansor N, Ali DE, Yaacob MR. Cosmetic usage in Malaysia: understanding of the major determinants affecting the users. Int J Bus Soc Sci. 2010;3:273–81. Mansor N, Ali DE, Yaacob MR. Cosmetic usage in Malaysia: understanding of the major determinants affecting the users. Int J Bus Soc Sci. 2010;3:273–81.
19.
go back to reference Dibaba H, Yadesa D, Legesse B, et al. Cosmetics utilization pattern and related adverse reactions among female university students. Int J Pharma Sci Res. 2013;4:997–1004. Dibaba H, Yadesa D, Legesse B, et al. Cosmetics utilization pattern and related adverse reactions among female university students. Int J Pharma Sci Res. 2013;4:997–1004.
20.
go back to reference Meharie BG, Ambaye AS, Thaimanot YM, et al. A cross sectional study on assessment of cosmetics utilization and self-reported adverse reactions among Wollo University, Dessie Campus Female Students, Dessie, North East Ethiopia. Eur J Pharm Med Res. 2014;2:49–63. Meharie BG, Ambaye AS, Thaimanot YM, et al. A cross sectional study on assessment of cosmetics utilization and self-reported adverse reactions among Wollo University, Dessie Campus Female Students, Dessie, North East Ethiopia. Eur J Pharm Med Res. 2014;2:49–63.
22.
go back to reference Degroot AC, Nater JP, Van der lendes R, et al. Adverse effects of cosmetics and toiletries: a retrospective study in the general population. Int J Cosmet Sci. 1987;9:255–9.CrossRef Degroot AC, Nater JP, Van der lendes R, et al. Adverse effects of cosmetics and toiletries: a retrospective study in the general population. Int J Cosmet Sci. 1987;9:255–9.CrossRef
23.
go back to reference Consumer’s Association. Reactions of the skin to cosmetic and Toiletry Products. Consumer’s Association survey. London: Pharmaceutical Press; 1979. Consumer’s Association. Reactions of the skin to cosmetic and Toiletry Products. Consumer’s Association survey. London: Pharmaceutical Press; 1979.
24.
go back to reference Gisele Huf G, Rito PN, Villas Bôas MHS. Adverse reactions to cosmetic products and the Notification System in Health Surveillance: a survey. Rev Bras Epidemiol. 2013;16:1017–20.CrossRefPubMed Gisele Huf G, Rito PN, Villas Bôas MHS. Adverse reactions to cosmetic products and the Notification System in Health Surveillance: a survey. Rev Bras Epidemiol. 2013;16:1017–20.CrossRefPubMed
26.
go back to reference Bianchi A, Cantù P, Firenzuoli F, et al. Rhabdomyolysiscaused by Commiphoramukul, a natural lipid-lowering agent. Ann Pharmacother. 2004;38:1222–5.CrossRefPubMed Bianchi A, Cantù P, Firenzuoli F, et al. Rhabdomyolysiscaused by Commiphoramukul, a natural lipid-lowering agent. Ann Pharmacother. 2004;38:1222–5.CrossRefPubMed
27.
go back to reference Bottenberg MM, Wall GC, Harvey RL, et al. Oral aloevera induced hepatitis. Ann Pharmacother. 2007;41:1740–3.CrossRefPubMed Bottenberg MM, Wall GC, Harvey RL, et al. Oral aloevera induced hepatitis. Ann Pharmacother. 2007;41:1740–3.CrossRefPubMed
28.
go back to reference Boullata JI, McDonnell PJ, Oliva CD. Anaphylactic reaction to a dietary supplement containing willow bark. Ann Pharmacother. 2003;37:832–5.CrossRefPubMed Boullata JI, McDonnell PJ, Oliva CD. Anaphylactic reaction to a dietary supplement containing willow bark. Ann Pharmacother. 2003;37:832–5.CrossRefPubMed
29.
go back to reference Richard CL, Jurgens TM. Effects of natural health products on blood pressure. Ann Pharmacother. 2005;39:712–20.CrossRefPubMed Richard CL, Jurgens TM. Effects of natural health products on blood pressure. Ann Pharmacother. 2005;39:712–20.CrossRefPubMed
30.
go back to reference Sleeper RB, Kennedy SM. Adverse reaction to a dietary supplement in an elderly patient. Ann Pharmacother. 2003;37:83–6.CrossRefPubMed Sleeper RB, Kennedy SM. Adverse reaction to a dietary supplement in an elderly patient. Ann Pharmacother. 2003;37:83–6.CrossRefPubMed
Metadata
Title
Cosmetics Use-Related Adverse Events and Determinants Among Jigjiga Town Residents, Eastern Ethiopia
Authors
Arebu I. Bilal
Zelalem Tilahun
Ebrahim D. Osman
Anwar Mulugeta
Muktar Shekabdulahi
Derbew Fikadu Berhe
Publication date
01-03-2017
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 1/2017
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-016-0157-y

Other articles of this Issue 1/2017

Dermatology and Therapy 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.